Barclays Reiterates Overweight Rating on Agilent Technologies, Inc. (A)

Market Context

Agilent Technologies, Inc. operates in the Healthcare sector. The stock currently trades at $131.63 with a market capitalization of $34.4B. The stock has declined 11.6% over the past 52 weeks.

Analyst coverage from Barclays provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Agilent Technologies, Inc..

Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.

Recent Analyst Activity for Agilent Technologies, Inc.

Among the 10 most recent ratings: 9 Buy, 1 Hold, 0 Sell.

Date	Firm	Rating	Price Target
Jun 24, 2026	Barclays	Overweight	N/A
Jun 11, 2026	Piper Sandler	Neutral	N/A
Jun 03, 2026	HSBC	Buy	N/A
Jun 02, 2026	B of A Securities	Buy	N/A
May 28, 2026	TD Cowen	Buy	N/A

Related Tools: Analyst Ratings Dashboard | View A Stock Page